Education:

M.S. Anhui Medical University, China, 2006;
Ph.D. China Pharmaceutical University, China, 2009

Research Interest:

Redox mechanism of endothelial dysfunction.
The role pH change in vascular disease.

Selected Publications:

Xu M, Ji H, Dai DZ, Tang XY, Dai Y. Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA 2a in rats. J Pharm Pharmacol. 2008; 60(6):739-45.

Xu M, Dai DZ, Dai Y. Normalizing NADPH Oxidase Contributes to Attenuating Diabetic Nephropathy by a Dual Endothelin Receptor Antagonist CPU 0213 in Rats. Am J Nephrol. 2008; 29(3):252-6.